Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.

Autor: Fasae KD; Department of Biochemistry, Molecular Drug Metabolism and Toxicology Unit, College of Medicine, University of Ibadan, Nigeria., Abolaji AO; Department of Biochemistry, Molecular Drug Metabolism and Toxicology Unit, College of Medicine, University of Ibadan, Nigeria. Electronic address: ao.abolaji@ui.edu.ng., Faloye TR; Department of Biochemistry, Molecular Drug Metabolism and Toxicology Unit, College of Medicine, University of Ibadan, Nigeria., Odunsi AY; Department of Biochemistry, Molecular Drug Metabolism and Toxicology Unit, College of Medicine, University of Ibadan, Nigeria., Oyetayo BO; Department of Pharmacology and Therapeutics, Neuropharmacology Unit, College of Medicine, University of Ibadan, Nigeria., Enya JI; Department of Anatomy, University of Ilorin, Kwara State, Nigeria., Rotimi JA; Department of Biochemistry and Molecular Biology, Obafemi Awolowo University, Ile-Ife, Nigeria., Akinyemi RO; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria., Whitworth AJ; MRC Mitochondria Biology Unit, University of Cambridge, UK., Aschner M; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: michael.aschner@einsteinmed.org.

Publikováno v: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) [J Trace Elem Med Biol] 2021 Sep; Vol. 67, pp. 126779. Date of Electronic Publication: 2021 May 15.